Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Decreases By 29.1%

PureTech Health plc (OTCMKTS:PTCHF) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 48,500 shares, a drop of 29.1% from the March 31st total of 68,400 shares. Based on an average daily trading volume, of 6,600 shares, the days-to-cover ratio is currently 7.3 days.

PureTech Health Stock Performance

Shares of PTCHF stock remained flat at $2.70 during mid-day trading on Monday. The company’s 50-day moving average is $2.64 and its two-hundred day moving average is $2.34. PureTech Health has a twelve month low of $1.69 and a twelve month high of $3.10.

About PureTech Health

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.